Showing results (281-290 of 342) with videos related to

Sort By:
Pageof 35
Contemporary Clinical Trials|November 17, 2022
Design, methods, and recruitment outcomes of the Veterans' Pain Care Organizational Improvement Comparative Effectiveness (VOICE) studyErin E Krebs, William C Becker, David Nelson, et al.
Genome Biology and Evolution|May 22, 2025
The Genome of Apera spica-venti: A Major Grass WeedJohn Lemas, Jevgenija Ņečajeva, Jacob Montgomery, et al.
Cellular Signalling|March 30, 2018
Heat shock protein 60 involvement in vascular smooth muscle cell proliferationJustin F Deniset, Thomas E Hedley, Markéta Hlaváčková, et al.
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|June 30, 2026
Rural cancer research activity across Europe: A bibliometric analysis on patterns, gaps and policy implicationsTanja K Kleinhappel, Natalia Calanzani, Samuel Cooke, et al.
Journal of the American Heart Association|October 27, 2023
Relationship of Race With Functional and Clinical Outcomes With the REHAB-HF Multidomain Physical Rehabilitation Intervention for Older Patients With Acute Heart FailureOlivia N Gilbert, Robert J Mentz, Alain G Bertoni, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 4, 2015
Generating and evaluating evidence of the clinical utility of molecular diagnostic tests in oncologyPatricia Deverka, Donna A Messner, Robert McCormack, et al.
Neurogenetics|August 15, 2012
Small genomic rearrangements involving FMR1 support the importance of its gene dosage for normal neurocognitive functionSandesh C S Nagamani, Ayelet Erez, Frank J Probst, et al.
European Journal of Gastroenterology & Hepatology|June 6, 2014
VX-222, a non-nucleoside NS5B polymerase inhibitor, in telaprevir-based regimens for genotype 1 hepatitis C virus infectionAdrian M Di Bisceglie, Mark Sulkowski, Ed Gane, et al.
Hepatology (Baltimore, Md.)|June 24, 2008
R1626 plus peginterferon Alfa-2a provides potent suppression of hepatitis C virus RNA and significant antiviral synergy in combination with ribavirinPaul J Pockros, David Nelson, Eliot Godofsky, et al.
Hepatology (Baltimore, Md.)|February 28, 2007
Final results of a double-blind, placebo-controlled trial of the antifibrotic efficacy of interferon-gamma1b in chronic hepatitis C patients with advanced fibrosis or cirrhosisPaul J Pockros, Lennox Jeffers, Nezam Afdhal, et al.
Pageof 35